Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,298 | 44,812 | 60,213 | 84,957 | 37,841 |
| Marketable Securities | 156,566 | 159,299 | 133,162 | 132,342 | 210,953 |
| Receivables | 6,882 | 8,357 | 40,628 | 40,162 | 38,645 |
| TOTAL | $204,336 | $222,708 | $242,860 | $268,145 | $299,852 |
| Non-Current Assets | |||||
| PPE Net | 35,395 | 36,617 | 37,572 | 37,368 | 32,688 |
| Other Non-Current Assets | 41,001 | 41,704 | 42,561 | 43,129 | 44,112 |
| TOTAL | $76,396 | $78,321 | $80,133 | $80,497 | $76,800 |
| Total Assets | $280,732 | $301,029 | $322,993 | $348,642 | $376,652 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,948 | 3,547 | 4,756 | 4,726 | 8,002 |
| Accrued Expenses | 12,751 | 10,853 | 8,314 | 10,575 | 13,547 |
| Other current liabilities | 30,710 | 27,755 | 30,681 | 32,743 | 34,462 |
| TOTAL | $48,555 | $44,549 | $45,947 | $49,050 | $57,535 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 167,460 | 177,201 | 183,508 | 187,776 | 190,303 |
| TOTAL | $167,460 | $177,201 | $183,508 | $187,776 | $190,303 |
| Total Liabilities | $216,015 | $221,750 | $229,455 | $236,826 | $247,838 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,863 | 21,378 | 21,377 | 21,333 | 21,194 |
| Common Shares | 214 | 214 | 214 | 213 | 212 |
| Retained earnings | -404,929 | -386,229 | -367,974 | -345,330 | -323,040 |
| Other shareholders' equity | -339 | -402 | -224 | -29 | 302 |
| TOTAL | $64,717 | $79,279 | $93,538 | $111,816 | $128,814 |
| Total Liabilities And Equity | $280,732 | $301,029 | $322,993 | $348,642 | $376,652 |